Listed by Matthews
$3,300,000
Grifols
Details
Property Type Office
Sub Type Medical Office
Square Footage 7,286
Cap Rate 6.81%
NOI $224,645
Occupancy 100%
Tenancy Single
Lease Type Absolute NNN
Lease Expiration 05/31/2027
Remaining Term 0.9
Price per SqFt $453
Class A
Year Built 1994
Acreage 0.430
Absolute NNN Grifols Plasma Center – Corporate Lease, 6.81% Cap, Prime Ogden Location
Investment highlights
- Strong Historical Occupancy: Biomat USA Plasma Center has operated from the Property since 2012 on a long-term Absolute NNN lease featuring two (2), five-year renewal option periods and attractive 3.00% annual rental escalations.
- Corporate Lease with Grifols: Grifols is a global biopharma company focused on plasma-derived medicines, and hospital/pharma services. Grifols is the largest plasma donation network in the world with 400+ centers located across North America, Europe, Africa/Middle East, and China. The company employs over 23,000 worldwide.
- Strong Global Revenue: Grifols reported $8.3 Billion USD in revenue for 2025, a 7.00% year-over-year increase.
- Strategic Investment in Biomat USA Platform: In 2021, sovereign wealth fund GIC invested approximately $1 billion into Biomat USA, validating the value of the U.S. plasma collection platform and supporting long-term growth.
- Prime Plasma Location: The Property is positioned less than one mile from Weber State University (an enrollment of over 32,000 students) where the property benefits from a strong and consistent flow of student, faculty, and community traffic.
- Highly-Trafficked Corridor: The Property is prominently positioned in a highly trafficked corridor with excellent access and visibility along Harrison Boulevard, a primary north-south arterial roadway in Ogden, featuring approximately 31,000 vehicles per day (VPD).
- High Ranking Brand: This location ranks in the top 81st percentile nationwide and 100th percentile in the City.
- Essential Healthcare Use with Growing Demand: Plasma-derived therapies such as immune deficiencies, pulmonary disorders, infectious diseases, and critical care conditions, creating durable global demand for plasma supply.
- FDA-Regulated Medical Facility: Plasma collection centers operate under strict FDA regulatory oversight, requiring licensing, quality protocols, and compliance procedures that create significant barriers to entry for new operators.
- Recession-Resilient Industry: Demand for plasma-derived therapies remains consistent across economic cycles due to their critical role in treating chronic and life-threatening medical conditions.
Listing Contacts
Listed by Matthews
Valuation Calculator
Login or Sign up to see Valuation Metrics
Sign up for Crexi to see valuation metrics for this property
Loan Amount
$0.00
Annual Debt Service
$--
$--
Annual Cash Flow
$224,645.00
$18,720.42/mo
Valuation Metrics
0
DSCR
6.81%
Cap Rate
6.81%
ROI
Broker Selected Comps View More Comps
Property History
Similar Properties
Additional Information
Name
License
Brokerage
Brokerage Phone
Title
Brokerage Address
Is there information that looks off?
